Elucidation of the Molecular Mechanisms of Action of the Natural Antimicrobial Peptide Subtilosin Against the Bacterial Vaginosis-associated Pathogen Gardnerella vaginalis

Probiotics and Antimicrobial Proteins

Volumn 3, Issue 1, 2011, Pages 41-47

  Noll, Katia Sutyak ^a   Sinko, Patrick J ^a   Chikindas, Michael L ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

Bacteriocin; Mode of action; Subtilosin; Vaginal pathogen

Indexed keywords

ADENOSINE TRIPHOSPHATE; BACTERIOCIN; POLYPEPTIDE ANTIBIOTIC AGENT; SUBTILOSIN; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; CELL DEATH; CELL PH; CELL TRANSPORT; CONTROLLED STUDY; DRUG MECHANISM; GARDNERELLA VAGINALIS; GROWTH INHIBITION; MEMBRANE POTENTIAL; NONHUMAN; PH MEASUREMENT; PRIORITY JOURNAL; PROTON MOTIVE FORCE;

BACILLUS AMYLOLIQUEFACIENS; BACTERIA (MICROORGANISMS); GARDNERELLA VAGINALIS;

EID: 79952484654     PISSN: 18671306     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12602-010-9061-4     Document Type: Article

References (41)

1. Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK (1983) Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 74: 14-22.
2. Babasaki K, Takao T, Shimonishi Y, Kurahashi K (1985) Subtilosin A, a new antibiotic peptide produced by Bacillus subtilis 168: isolation, structural analysis, and biogenesis. J Biochem 98: 585-603.
3. Bannatyne RM, Smith AM (1998) Recurrent bacterial vaginosis and metronidazole resistance in Gardnerella vaginalis. Sex Transm Infect 74: 455-456.
4. Bauer R, Chikindas ML, Dicks LMT (2005) Purification, partial amino acid sequence and mode of action of pediocin PD-1, a bacteriocin produced by Pediococcus damnosus NCFB 1832. Int J Food Microbiol 101: 17-27.
5. Chikindas ML, García-Garcerá MJ, Driessen AJ, Ledeboer AM, Nissen-Meyer J, Nes IF, Abee T, Konings WN, Venema G (1993) Pediocin PA-1, a bacteriocin from Pediococcus acidilactici PAC1. 0, forms hydrophilic pores in the cytoplasmic membrane of target cells. Appl Environ Microbiol 59: 3577-3584.
6. Christensen DP, Hutkins RW (1992) Collapse of the proton motive force in Listeria monocytogenes caused by a bacteriocin produced by Pediococcus acidilactici. Appl Environ Microbiol 58: 3312-3315.
7. Cotter PD, Hill C, Ross RP (2005) Bacteriocins: developing innate immunity for food. Nat Rev Microbiol 10: 777-788.
8. Eckert LO, Moore DE, Patton DL, Agnew KJ, Eschenbach DA (2003) Relationship of vaginal bacteria and inflammation with conception and early pregnancy loss following in vitro fertilization. Infect Dis Obstet Gynecol 11: 11-17.
9. Falagas ME, Betsi GI, Athanasiou S (2007) Probiotics for the treatment of women with bacterial vaginosis. Clin Microbiol Infect 13: 657-664.
10. Gibbs RS (2007) Asymptomatic bacterial vaginosis: is it time to treat? Am J Obstet Gynecol 196: 495-496.
11. Goldenberg RL, Culhane JF, Johnson DC (2005) Maternal infection and adverse fetal and neonatal outcomes. Clin Perinatol 32: 523-529.
12. Gould GW, Leistner L (2005) Update on hurdle technology approaches to food preservation. In: Davidson PM, Sofos JN, Branen AL (eds) Antimicrobials in food, 3rd edn. CRC Press, Boca Raton, pp 621-630.
13. Guihard G, Bénédetti H, Besnard M, Letellier L (1993) Phosphate efflux through the channels formed by colicins and phage T5 in Escherichia coli cells is responsible for the fall in cytoplasmic ATP. J Biol Chem 268: 17775-17780.
14. Haggerty CL, Hillier SL, Bass DC, Ness RB, PID Evaluation and Clinical Health Study Investigators (2004) Bacterial vaginosis and anaerobic bacteria are associated with endometritis. Clin Infect Dis 39: 990-995.
15. Hashemi FB, Ghassemi M, Roebuck KA, Spear GT (1999) Activation of human immunodeficiency virus type 1 expression by Gardnerella vaginalis. J Infect Dis 179: 924-930.
16. Hashemi FB, Ghassemi M, Faro S, Aroutcheva A, Spear GT (2000) Induction of human immunodeficiency virus type 1 expression by anaerobes associated with bacterial vaginosis. J Infect Dis 181: 1574-1580.
17. Herranz C, Chen Y, Chung HJ, Cintas LM, Hernandez PE, Montville TJ, Chikindas ML (2001) Enterocin P selectively dissipates the membrane potential of Enterococcus faecium T136. Appl Environ Microbiol 67: 1689-1692.
18. Hillier SL, Nugent RP, Eschenbach DA, Krohn MA, Gibbs RS, Martin DH, Cotch MF, Edelman R, Pastorek JG 2nd, Rao AV, McNellis D, Regan JA, Carey JC, Klebanoff MA (1995) Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med 333: 1737-1742.
19. Hsu S-T, Breukink E, de Kruiff B, Kaptein R, Bonvin AMJJ, van Nuland NAJ (2002) Mapping the targeted membrane pore formation mechanism by solution NMR: the Nisin Z and lipid II interaction in SDS micelles. Biochemistry 41: 7670-7676.
20. Hsu S-T, Breukink E, Bierbaum G, Sahl HG, de Kruiff B, Kaptein R, van Nuland NAJ, Bonvin AMJJ (2003) NMR study of mersacidin and lipid II interaction in dodecylphosphocholine micelles. Conformational changes are a key to antimicrobial activity. J Biol Chem 278: 13110-13117.
21. Liebetrau A, Rodloff AC, Behra-Miellet J, Dubreuil L (2003) In vitro activities of a new des-fluoro(6) quinolone, garenoxacin, against clinical anaerobic bacteria. Antimicrob Agents Chemother 47: 3667-3671.
22. Lin L, Song J, Kimber N, Shott S, Tangora J, Aroutcheva A, Mazees MB, Wells A, Cohen A, Faro S (1999) The role of bacterial vaginosis in infection after major gynecologic surgery. Infect Dis Obstet Gynecol 7: 169-174.
23. Lubbe MM, Botha PL, Chalkley LJ (1999) Comparative activity of eighteen antimicrobial agents against anaerobic bacteria isolated in South Africa. Eur J Clin Microbiol Infect Dis 18: 46-54.
24. Marx R, Stein T, Entian KD, Glaser SJ (2001) Structure of the Bacillus subtilis peptide antibiotic subtilosin A determined by 1H NMR and matrix assisted laser desorption/ionization time-of-flight mass spectrometry. J Protein Chem 20: 501-506.
25. Molenaar D, Abee T, Konings WN (1991) Continuous measurement of the cytoplasmic pH in Lactococcus lactis with a fluorescent pH indicator. Biochim Biophys Acta 1115: 75-83.
26. Nelson DB, Bellamy S, Nachamkin I, Ness RB, Macones GA, Allen-Taylor L (2007) First trimester bacterial vaginosis, individual microorganism levels, and risk of second trimester pregnancy loss among urban women. Fertil Steril 88: 1396-1403.
27. Newton ER, Piper J, Peairs W (1997) Bacterial vaginosis and intraamniotic infection. Am J Obstet Gynecol 176: 672-677.
28. Oakeshott P, Kerry S, Hay S, Hay P (2004) Bacterial vaginosis and preterm birth: a prospective community-based cohort study. Br J Gen Pract 54: 119-122.
29. Sewankambo N, Gray RH, Wawer MJ, Paxton L, McNaim D, Wabwire-Mangen F, Serwadda D, Li C, Kiwanuka N, Hillier SL, Rabe L, Gaydos CA, Quinn TC, Konde-Lule J (1997) HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet 350: 546-550.
30. Shelburne CE, An FY, Dholpe V, Ramamoorthy A, Lopatin DE, Lantz MS (2007) The spectrum of antimicrobial activity of the bacteriocin subtilosin A. J Antimicrob Chemother 59: 297-300.
31. Silkin L, Hamza S, Kaufman S, Cobb SL, Vederas JC (2008) Spermicidal bacteriocins: lacticin 3147 and subtilosin A. Bioorg Med Chem Lett 18: 3103-3106.
32. Sims PJ, Waggoner AS, Wang CH, Hoffman JF (1974) Studies on the mechanism by which cyanine dyes measure membrane potential in red blood cells and phosphatidylcholine vesicles. Biochemistry 13: 3315-3330.
33. Srinivasan S, Fredericks DN (2008) The human vaginal bacterial biota and bacterial vaginosis. Interdiscip Perspect Infect Dis 2008: 750479.
34. Stein T, Düsterhus S, Stroh A, Entian KD (2004) Subtilosin production by two Bacillus subtilis subspecies and variance of the sbo-alb cluster. Appl Environ Microbiol 70: 2349-2353.
35. Sutyak KE, Wirawan RE, Aroutcheva AA, Chikindas ML (2007) Isolation of the Bacillus subtilis antimicrobial peptide from the dairy product-derived Bacillus amyloliquefaciens. J Appl Microbiol 104: 1067-1074.
36. Sutyak KE, Anderson RA, Dover SE, Feathergill KA, Aroutcheva AA, Faro S, Chikindas ML (2008) Spermicidal activity of the safe natural antimicrobial peptide subtilosin. Infect Dis Obstet Gynecol 2008: 540758.
37. Taha TE, Gray RH, Kumwenda NI, Hoover DR, Mtimavalye LA, Liomba GN, Chiphangwi JD, Dallabetta GA, Miotti PG (1999) HIV infection and disturbances of vaginal flora during pregnancy. J Acquir Immune Defic Syndr Hum Retrovirol 20: 52-59.
38. Thennarasu S, Lee D-K, Poon A, Kawulka KE, Vederas JC, Ramamoorthy A (2005) Membrane permeabilization, orientation, and antimicrobial mechanism of subtilosin A. Chem Phys Lipids 137: 38-51.
39. Turvoskiy Y, Ludescher RD, Aroutcheva AA, Faro S, Chikindas ML (2009) Lactocin 160, a bacteriocin produced by vaginal Lactobacillus rhamnosus, targets cytoplasmic membranes of the vaginal pathogen, Gardnerella vaginalis. Probiotics Antimicrob Proteins 1: 67-74.
40. Weir E (2004) Bacterial vaginosis: more questions than answers. Can Med Assoc J 171: 448.
41. Winkowski K, Bruno MEC, Montville TJ (1994) Correlation of bioenergetic parameters with cell death in Listeria monocytogenes cells exposed to nisin. Appl Envrion Microbiol 60: 4186-4188.